KEGG MEDICUS 医薬品情報 |
利用法 Top |
エントリ | 名称 | カテゴリ | パスウェイ | 病因遺伝子 |
---|---|---|---|---|
H00202 | 肝性ポルフィリン症 | 先天性代謝異常症 |
(PCT) UROD [HSA:7389] [KO:K01599] (AIP) HMBS [HSA:3145] [KO:K01749] (VP) PPOX [HSA:5498] [KO:K00231] (ALADP) ALAD [HSA:210] [KO:K01698] (HCP) CPOX [HSA:1371] [KO:K00228] |
|
H00203 |
無カタラーゼ血症 高原病 |
先天性代謝異常症 | CAT [HSA:847] [KO:K03781] | |
H00204 | Heimler 症候群 | 先天性代謝異常症, ペルオキシソーム病 |
(HMLR1) PEX1 [HSA:5189] [KO:K13338] (HMLR2) PEX6 [HSA:5190] [KO:K13339] |
|
H00205 | ペルオキシソーム形成異常症 | 先天性代謝異常症, ペルオキシソーム病 |
(PBD1A/1B) PEX1 [HSA:5189] [KO:K13338] (PBD2A/2B) PEX5 [HSA:5830] [KO:K13342] (PBD3A/3B) PEX12 [HSA:5193] [KO:K13345] (PBD4A/4B) PEX6 [HSA:5190] [KO:K13339] (PBD5A/5B) PEX2 [HSA:5828] [KO:K06664] (PBD6A/6B) PEX10 [HSA:5192] [KO:K13346] (PBD7A/7B) PEX26 [HSA:55670] [KO:K13340] (PBD8A/8B) PEX16 [HSA:9409] [KO:K13335] (PBD9B) PEX7 [HSA:5191] [KO:K13341] (PBD10A) PEX3 [HSA:8504] [KO:K13336] (PBD11A/11B) PEX13 [HSA:5194] [KO:K13344] (PBD12A) PEX19 [HSA:5824] [KO:K13337] (PBD13A) PEX14 [HSA:5195] [KO:K13343] (PBD14B) PEX11B [HSA:8799] [KO:K13352] |
|
H00206 | メバロン酸キナーゼ欠損症 | 先天性代謝異常症 | MVK [HSA:4598] [KO:K00869] | |
H00207 | 肢根型点状軟骨異形成症 | 先天性代謝異常症, ペルオキシソーム病 |
(RCDP1) PEX7 [HSA:5191] [KO:K13341] (RCDP2) GNPAT [HSA:8443] [KO:K00649] (RCDP3) AGPS [HSA:8540] [KO:K00803] (RCDP4) FAR1 [HSA:84188] [KO:K13356] (RCDP5) PEX5 [HSA:5830] [KO:K13342] |
|
H00208 | 高ビリルビン血症 | 先天性代謝異常症 |
(CN1, CN2) UGT1A1 [HSA:54658] [KO:K00699] (DJS) ABCC2 [HSA:1244] [KO:K05666] (RS) SLCO1B1 [HSA:10599] [KO:K05043] (RS) SLCO1B3 [HSA:28234] [KO:K05043] |
|
H00209 | メンケス症候群 | 先天性代謝異常症 | ATP7A [HSA:538] [KO:K17686] | |
H00210 |
ウィルソン病 肝レンズ核変性症 |
先天性代謝異常症 | ATP7B [HSA:540] [KO:K17686] | |
H00211 | ヘモクロマトーシス | 先天性代謝異常症 |
(HFE1) HFE [HSA:3077] [KO:K26535] (HFE2A) HJV [HSA:148738] [KO:K23100] (HFE2B) HAMP [HSA:57817] [KO:K23106] (HFE3) TFR2 [HSA:7036] [KO:K23910] (HFE4) SLC40A1 [HSA:30061] [KO:K14685] (HFE5) FTH1 [HSA:2495] [KO:K00522] |
|
H00212 | 腸性肢端皮膚炎 | 先天性代謝異常症 | SLC39A4 [HSA:55630] [KO:K14710] | |
H00213 | 低ホスファターゼ症 | 先天性代謝異常症 | ALPL [HSA:249] [KO:K01077] | |
H00214 | 低リン血症性くる病 | 先天性代謝異常症 |
(XLHR) PHEX [HSA:5251] [KO:K08636] (XLRH) CLCN5 [HSA:1184] [KO:K05012] (ADHR) FGF23 [HSA:8074] [KO:K22428] (ARHR1) DMP1 [HSA:1758] [KO:K23328] (ARHR2) ENPP1 [HSA:5167] [KO:K01513] (HHRH) SLC34A3 [HSA:142680] [KO:K14683] |
|
H00215 | 遺伝性周期性四肢麻痺 | 神経系疾患; 筋骨格疾患 |
(HYPP HOKPP2) SCN4A [HSA:6329] [KO:K04837] (HOKPP1) CACNA1S [HSA:779] [KO:K04857] (ATS) KCNJ2 [HSA:3759] [KO:K04996] |
|
H00216 |
先天性副腎過形成症 先天性副腎酵素欠損症 |
内分泌代謝疾患 |
STAR [HSA:6770] [KO:K16931] HSD3B2 [HSA:3284] [KO:K00070] CYP21A2 [HSA:1589] [KO:K00513] CYP11B1 [HSA:1584] [KO:K00497] CYP17A1 [HSA:1586] [KO:K00512] |
|
H00217 | 肺胞蛋白症 | 呼吸器系疾患 | ||
H00218 | 嚢胞性線維症 | 呼吸器系疾患 |
CFTR [HSA:1080] [KO:K05031] TGFB1 [HSA:7040] [KO:K13375] FCGR2A [HSA:2212] [KO:K06472] |
|
H00219 | 血友病 | 血液疾患 |
(HEMA) F8 [HSA:2157] [KO:K03899] (HEMB) F9 [HSA:2158] [KO:K01321] (VWD) VWF [HSA:7450] [KO:K03900] (VWDP) GP1BA [HSA:2811] [KO:K06261] |
|
H00220 | 第V因子欠損症 | 血液疾患 | F5 [HSA:2153] [KO:K03902] | |
H00221 | 第Vおよび第VIII因子合併欠乏症 | 血液疾患 |
LMAN1 [HSA:3998] [KO:K10080] MCFD2 [HSA:90411] [KO:K20364] |
|
H00222 |
無フィブリノゲン血症 異常フィブリノーゲン血症 |
血液疾患 |
FGA [HSA:2243] [KO:K03903] FGB [HSA:2244] [KO:K03904] FGG [HSA:2266] [KO:K03905] |
|
H00223 | 遺伝性血栓性素因 | 血液疾患 |
(THPH1) F2 [HSA:2147] [KO:K01313] (THPH2) F5 [HSA:2153] [KO:K03902] (THPH3/4) PROC [HSA:5624] [KO:K01344] (THPH5/6) PROS1 [HSA:5627] [KO:K03908] (THPH7) SERPINC1 [HSA:462] [KO:K03911] (THPH8) F9 [HSA:2158] [KO:K01321] (THPH10) SERPIND1 [HSA:3053] [KO:K03912] (THPH11) HRG [HSA:3273] [KO:K23410] (THPH12) THBD [HSA:7056] [KO:K03907] (THPH13) F8 [HSA:2157] [KO:K03899] FGA [HSA:2243] [KO:K03903] FGB [HSA:2244] [KO:K03904] FGG [HSA:2266] [KO:K03905] |
|
H00224 | ベルナール・スーリエ症候群 | 血液疾患 |
GP1BA [HSA:2811] [KO:K06261] GP1BB [HSA:2812] [KO:K06262] GP9 [HSA:2815] [KO:K06263] |
|
H00225 | 血栓性血小板減少性紫斑病 | 循環器系疾患 | ADAMTS13 [HSA:11093] [KO:K08627] | |
H00226 | グランツマン血小板無力症 | 血液疾患 |
(GT1) ITGA2B [HSA:3674] [KO:K06476] (GT2) ITGB3 [HSA:3690] [KO:K06493] |
|
H00227 | 先天性無巨核球性血小板減少症 | 血液疾患 |
(CAMT1) MPL [HSA:4352] [KO:K05082] (CAMT2) THPO [HSA:7066] [KO:K06854] |
|
H00228 | サラセミア | 血液疾患 |
(Alpha) HBA1 [HSA:3039] [KO:K13822] (Alpha) HBA2 [HSA:3040] [KO:K13822] (Beta) HBB [HSA:3043] [KO:K13823] (Beta) HBG1 [HSA:3047] [KO:K13824] (Beta) HBG2 [HSA:3048] [KO:K13824] (ATRX) ATRX [HSA:546] [KO:K10779] |
|
H00229 |
鎌状赤血球症 鎌状赤血球貧血 |
血液疾患 | HBB [HSA:3043] [KO:K13823] | |
H00230 | 遺伝性球状赤血球症 | 血液疾患 |
(SPH1) ANK1 [HSA:286] [KO:K10380] (SPH2) SPTB [HSA:6710] [KO:K27409] (SPH3) SPTA1 [HSA:6708] [KO:K27408] (SPH4) SLC4A1 [HSA:6521] [KO:K06573] (SPH5) EPB42 [HSA:2038] [KO:K25094] |
|
H00231 | 遺伝性楕円赤血球症 | 血液疾患 |
(EL1) EPB41 [HSA:2035] [KO:K06107] (EL2) SPTA1 [HSA:6708] [KO:K27408] (EL3) SPTB [HSA:6710] [KO:K27409] |
|
H00232 | 遺伝性有口赤血球症 | 血液疾患 |
(OHST) RHAG [HSA:6005] [KO:K06580] (DHS1) PIEZO1 [HSA:9780] [KO:K22128] (DHS2) KCNN4 [HSA:3783] [KO:K04945] (PSHK2) ABCB6 [HSA:10058] [KO:K05661] (CHC) SLC4A1 [HSA:6521] [KO:K06573] (SDCHCN) SLC2A1 [HSA:6513] [KO:K07299] |
|
H00233 |
MYH9 異常症 腎炎や感音性難聴を伴う(伴わない)巨大血小板性血小板減少症及び顆粒球内封入体 (MATINS) |
循環器系疾患 | MYH9 [HSA:4627] [KO:K10352] | |
H00234 | ペルゲル・フエット核異常 | 血液疾患 | LBR [HSA:3930] [KO:K19532] | |
H00235 | メトヘモグロビン血症 | 血液疾患 |
CYB5R3 [HSA:1727] [KO:K00326] CYB5A [HSA:1528] [KO:K23490] HBA1 [HSA:3039] [KO:K13822] HBB [HSA:3043] [KO:K13823] |
|
H00236 |
先天性赤血球増加症 家族性赤血球増加症 |
血液疾患 |
(ECYT1) EPOR [HSA:2057] [KO:K05079] (ECYT1) JAK2 [HSA:3717] [KO:K04447] (ECYT1) SH2B3 [HSA:10019] [KO:K12459] (ECYT2) VHL [HSA:7428] [KO:K03871] (ECYT3) EGLN1 [HSA:54583] [KO:K09592] (ECYT4) EPAS1 [HSA:2034] [KO:K09095] (ECYT5) EPO [HSA:2056] [KO:K05437] (ECYT6) HBB [HSA:3043] [KO:K13823] (ECYT7) HBA1/2 [HSA:3039 3040] [KO:K13822] (ECYT8) BPGM [HSA:669] [KO:K01837] |
|
H00237 | ダイアモンド・ブラックファン貧血 | リボソーム病 |
(DBA1) RPS19 [HSA:6223] [KO:K02966] (DBA3) RPS24 [HSA:6229] [KO:K02974] (DBA4) RPS17 [HSA:6218] [KO:K02962] (DBA5) RPL35A [HSA:6165] [KO:K02917] (DBA6) RPL5 [HSA:6125] [KO:K02932] (DBA7) RPL11 [HSA:6135] [KO:K02868] (DBA8) RPS7 [HSA:6201] [KO:K02993] (DBA9) RPS10 [HSA:6204] [KO:K02947] (DBA10) RPS26 [HSA:6231] [KO:K02976] (DBA11) RPL26 [HSA:6154] [KO:K02898] (DBA12) RPL15 [HSA:6138] [KO:K02877] (DBA13) RPS29 [HSA:6235] [KO:K02980] (DBA14) TSR2 [HSA:90121] [KO:K14800] (DBA15) RPS28 [HSA:6234] [KO:K02979] (DBA16) RPL27 [HSA:6155] [KO:K02901] (DBA17) RPS27 [HSA:6232] [KO:K02978] (DBA18) RPL18 [HSA:6141] [KO:K02883] (DBA19) RPL35 [HSA:11224] [KO:K02918] (DBA20) RPS15A [HSA:6210] [KO:K02957] (DBA21) HEATR3 [HSA:55027] [KO:K24812] |
|
H00238 | ファンコニ貧血 | 血液疾患 |
(FANCA) FANCA [HSA:2175] [KO:K10888] (FANCB) FANCB [HSA:2187] [KO:K10889] (FANCC) FANCC [HSA:2176] [KO:K10890] (FANCD1) BRCA2 [HSA:675] [KO:K08775] (FANCD2) FANCD2 [HSA:2177] [KO:K10891] (FANCE) FANCE [HSA:2178] [KO:K10892] (FANCF) FANCF [HSA:2188] [KO:K10893] (FANCG) FANCG [HSA:2189] [KO:K10894] (FANCI) FANCI [HSA:55215] [KO:K10895] (FANCJ) BRIP1 [HSA:83990] [KO:K15362] (FANCL) FANCL [HSA:55120] [KO:K10606] (FANCM) FANCM [HSA:57697] [KO:K10896] (FANCN) PALB2 [HSA:79728] [KO:K10897] (FANCO) RAD51C [HSA:5889] [KO:K10870] (FANCP) SLX4 [HSA:84464] [KO:K10484] (FANCQ) ERCC4 [HSA:2072] [KO:K10848] (FANCR) RAD51 [HSA:5888] [KO:K04482] (FANCS) BRCA1 [HSA:672] [KO:K10605] (FANCT) UBE2T [HSA:29089] [KO:K13960] (FANCU) XRCC2 [HSA:7516] [KO:K10879] (FANCV) MAD2L2 [HSA:10459] [KO:K13728] (FANCW) RFWD3 [HSA:55159] [KO:K15691] |
|
H00239 | バーター症候群 | 内分泌代謝疾患 |
(BARTS1) SLC12A1 [HSA:6557] [KO:K14425] (BARTS2) KCNJ1 [HSA:3758] [KO:K04995] (BARTS3) CLCNKB [HSA:1188] [KO:K05018] (BARTS4A) BSND [HSA:7809] [KO:K19331] (BARTS4B) CLCNKA,CLCNKB (double mutation) [HSA:1187 1188] [KO:K05017 K05018] (BARTS5) MAGED2 [HSA:10916] [KO:K24127] (HYPOC1) CASR [HSA:846] [KO:K04612] |
|
H00240 | ギテルマン症候群 | 内分泌代謝疾患 | SLC12A3 [HSA:6559] [KO:K14426] | |
H00241 | 尿細管性アシドーシス III 型 | 泌尿器系疾患 | CA2 [HSA:760] [KO:K18245] |
[ KEGG | KEGG DRUG | KEGG MEDICUS ] |